Format
Sort by
Items per page

Send to

Choose Destination

Best matches for DeLarochellière R[au]:

Search results

Items: 1 to 50 of 64

1.

Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials.

Maes F, Jolly SS, Cairns J, Delarochellière R, Côté M, Dzavik V, Rodés-Cabau J.

J Invasive Cardiol. 2019 Nov;31(11):E308-E315.

2.

Significant mitral regurgitation in patients undergoing TAVR: Mechanisms and imaging variables associated with improvement.

Chiche O, Rodés-Cabau J, Campelo-Parada F, Freitas-Ferraz AB, Regueiro A, Chamandi C, Rodriguez-Gabella T, Côté M, DeLarochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Bergeron S, Pibarot P, Beaudoin J.

Echocardiography. 2019 Apr;36(4):722-731. doi: 10.1111/echo.14303. Epub 2019 Mar 4.

PMID:
30834579
3.

Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement.

Vilalta V, Asmarats L, Ferreira-Neto AN, Maes F, de Freitas Campos Guimarães L, Couture T, Paradis JM, Mohammadi S, Dumont E, Kalavrouziotis D, Delarochellière R, Rodés-Cabau J.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2523-2533. doi: 10.1016/j.jcin.2018.09.001.

PMID:
30573061
4.

Transcarotid Compared With Other Alternative Access Routes for Transcatheter Aortic Valve Replacement.

Chamandi C, Abi-Akar R, Rodés-Cabau J, Blanchard D, Dumont E, Spaulding C, Doyle D, Pagny JY, DeLarochellière R, Lafont A, Paradis JM, Puri R, Karam N, Maes F, Rodriguez-Gabella T, Chassaing S, Le Page O, Kalavrouziotis D, Mohammadi S.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006388. doi: 10.1161/CIRCINTERVENTIONS.118.006388.

PMID:
30571205
5.

Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels: initial experience with the Essential paclitaxel-coated balloon.

Abellas-Sequeiros RA, Benezet J, Agarrado Luna A, Oneto Otero J, Déry JP, Cieza T, DeLarochellière R, Duocastella L, Gomez A, Molina M, Asmarats L, Pelletier-Beaumont E, Puri R, Rodés-Cabau J.

Coron Artery Dis. 2018 Sep;29(6):477-481. doi: 10.1097/MCA.0000000000000617.

PMID:
29621009
6.

Transradial experience with bioresorbable vascular scaffolds: A case-matched study with metallic drug-eluting stents.

Maes F, Costerousse O, Cieza T, Henry M, Déry JP, Barbeau G, Delarochellière R, Paradis JM, Larose E, Nguyen CM, Pirlet C, Mongrain R, Bertrand OF.

Cardiovasc Revasc Med. 2018 Sep;19(6):700-704. doi: 10.1016/j.carrev.2018.01.002. Epub 2018 Jan 6.

PMID:
29398632
7.

Cerebral Embolism Following Transcarotid Transcatheter Aortic Valve Replacement.

Chamandi C, Mohammadi S, Dumont E, Doyle D, DeLarochellière R, Paradis JM, Puri R, Pasian S, Pelletier-Beaumont É, Rodés-Cabau J.

J Am Coll Cardiol. 2018 Jan 2;71(1):101-102. doi: 10.1016/j.jacc.2017.10.075. No abstract available.

8.

Predictors and Association With Clinical Outcomes of the Changes in Exercise Capacity After Transcatheter Aortic Valve Replacement.

Abdul-Jawad Altisent O, Puri R, Regueiro A, Chamandi C, Rodriguez-Gabella T, Del Trigo M, Campelo-Parada F, Couture T, Marsal JR, Côté M, Paradis JM, DeLarochellière R, Doyle D, Mohammadi S, Dumont E, Rodés-Cabau J.

Circulation. 2017 Aug 15;136(7):632-643. doi: 10.1161/CIRCULATIONAHA.116.026349. Epub 2017 Jun 6.

PMID:
28588077
9.

Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty.

Campelo-Parada F, Nombela-Franco L, Urena M, Regueiro A, Jiménez-Quevedo P, Del Trigo M, Chamandi C, Rodríguez-Gabella T, Auffret V, Abdul-Jawad Altisent O, DeLarochellière R, Paradis JM, Dumont E, Philippon F, Pérez-Castellano N, Puri R, Macaya C, Rodés-Cabau J.

Rev Esp Cardiol (Engl Ed). 2018 Mar;71(3):162-169. doi: 10.1016/j.rec.2017.04.010. Epub 2017 May 27. English, Spanish.

PMID:
28566243
10.

Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.

Paradis JM, White JM, Généreux P, Urena M, Doshi D, Nazif T, Hahn R, George I, Khalique O, Harjai K, Lasalle L, Labbé BM, DeLarochellière R, Doyle D, Dumont É, Mohammadi S, Leon MB, Rodés-Cabau J, Kodali S.

J Am Heart Assoc. 2017 Feb 20;6(2). pii: e005070. doi: 10.1161/JAHA.116.005070.

11.

Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial.

Urena M, Del Trigo M, Altisent OA, Campelo-Prada F, Regueiro A, DeLarochellière R, Doyle D, Mohammadi S, Paradis JM, Dagenais F, Dumont E, Puri R, Laroche V, Rodés-Cabau J.

EuroIntervention. 2017 May 15;13(1):44-52. doi: 10.4244/EIJ-D-16-00591.

PMID:
28067195
12.

Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.

Rodés-Cabau J, Jolly SS, Cairns J, Mansour S, L'Allier PL, Teefy PJ, Graham JJ, Le May MR, Cantor WJ, Wood D, Balasubramanian K, DeLarochellière R, Dzavik V; VELETI II Investigators (Sealing Moderate Coronary Saphenous Vein Graft Lesions With Paclitaxel-Eluting Stents).

Circ Cardiovasc Interv. 2016 Nov;9(11). pii: e004336.

PMID:
27815344
13.

Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.

Campelo-Parada F, Regueiro A, Dumont E, DeLarochellière R, Paradis JM, Mohammadi S, Doyle D, Rodés-Cabau J.

J Card Surg. 2016 Oct;31(10):617-622. doi: 10.1111/jocs.12822. Epub 2016 Aug 30.

PMID:
27577965
14.

Stuck Leaflet After Transcatheter Aortic Valve Replacement With a SAPIEN-3 Valve: New Valve, Old Complication.

Couture EL, Labbé BM, DeLarochellière R, Rodés-Cabau J, Paradis JM.

JACC Cardiovasc Interv. 2016 Jul 25;9(14):e133-5. doi: 10.1016/j.jcin.2016.04.041. Epub 2016 Jun 29. No abstract available.

15.

Prognostic Value of Fat Mass and Skeletal Muscle Mass Determined by Computed Tomography in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Mok M, Allende R, Leipsic J, Altisent OA, Del Trigo M, Campelo-Parada F, DeLarochellière R, Dumont E, Doyle D, Côté M, Freeman M, Webb J, Rodés-Cabau J.

Am J Cardiol. 2016 Mar 1;117(5):828-33. doi: 10.1016/j.amjcard.2015.12.015. Epub 2015 Dec 13.

PMID:
26754122
16.

Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance.

Del Trigo M, Dahou A, Webb JG, Dvir D, Puri R, Abdul-Jawad Altisent O, Campelo-Parada F, Thompson C, Leipsic J, Stub D, DeLarochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Pasian S, Côté M, Pibarot P, Rodés-Cabau J.

Rev Esp Cardiol (Engl Ed). 2016 May;69(5):501-8. doi: 10.1016/j.rec.2015.08.019. Epub 2015 Dec 29. English, Spanish.

PMID:
26739827
17.

Transcatheter mitral valve implantation for inoperable severely calcified native mitral valve disease: A systematic review.

Puri R, Abdul-Jawad Altisent O, del Trigo M, Campelo-Parada F, Regueiro A, Barbosa Ribeiro H, DeLarochellière R, Paradis JM, Dumont E, Rodés-Cabau J.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):540-8. doi: 10.1002/ccd.26262. Epub 2015 Nov 18. Review.

PMID:
26577250
18.

Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.

Nombela-Franco L, del Trigo M, Morrison-Polo G, Veiga G, Jimenez-Quevedo P, Abdul-Jawad Altisent O, Campelo-Parada F, Biagioni C, Puri R, DeLarochellière R, Dumont E, Doyle D, Paradis JM, Quirós A, Almeria C, Gonzalo N, Nuñez-Gil I, Salinas P, Mohammadi S, Escaned J, Fernández-Ortiz A, Macaya C, Rodés-Cabau J.

JACC Cardiovasc Interv. 2015 Nov;8(13):1748-57. doi: 10.1016/j.jcin.2015.07.022.

19.

Jailing of a Pacemaker Lead During Tricuspid Valve-in-Valve Implantation With an Edwards SAPIEN XT Transcatheter Heart Valve.

Paradis JM, Bernier M, Houde C, Dumont É, Doyle D, Mohammadi S, DeLarochellière R, Philippon F, Rodés-Cabau J.

Can J Cardiol. 2015 Jun;31(6):819.e9-11. doi: 10.1016/j.cjca.2015.01.037. Epub 2015 Feb 4. No abstract available.

PMID:
25935882
20.

Myocardial Injury After Transaortic Versus Transapical Transcatheter Aortic Valve Replacement.

Ribeiro HB, Dahou A, Urena M, Carrasco JL, Mohammadi S, Doyle D, Le Ven F, Allende R, Amat-Santos I, Paradis JM, DeLarochellière R, Puri R, Abdul-Jawad Altisent O, del Trigo M, Campelo-Parada F, Pibarot P, Dumont É, Rodés-Cabau J.

Ann Thorac Surg. 2015 Jun;99(6):2001-9. doi: 10.1016/j.athoracsur.2015.01.029. Epub 2015 Apr 8.

PMID:
25863732
21.

Incidence and risk factors of hemolysis after transcatheter aortic valve implantation with a balloon-expandable valve.

Laflamme J, Puri R, Urena M, Laflamme L, DeLarochellière H, Abdul-Jawad Altisent O, del Trigo M, Campelo-Parada F, DeLarochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Côté M, Pibarot P, Laroche V, Rodés-Cabau J.

Am J Cardiol. 2015 Jun 1;115(11):1574-9. doi: 10.1016/j.amjcard.2015.02.059. Epub 2015 Mar 12.

PMID:
25862156
22.

Transcatheter mitral "valve-in-ring" implantation: a word of caution.

Allende R, Doyle D, Urena M, Ribeiro HB, Amat-Santos IJ, Bernier M, Pasian S, DeLarochellière R, Dumont E, Rodés-Cabau J.

Ann Thorac Surg. 2015 Apr;99(4):1439-42. doi: 10.1016/j.athoracsur.2014.06.083.

PMID:
25841832
23.

Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review.

Amat-Santos IJ, Ribeiro HB, Urena M, Allende R, Houde C, Bédard E, Perron J, DeLarochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Côté M, San Roman JA, Rodés-Cabau J.

JACC Cardiovasc Interv. 2015 Feb;8(2):334-346. doi: 10.1016/j.jcin.2014.09.013. Review.

24.

Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement.

DeLarochellière H, Urena M, Amat-Santos IJ, Ribeiro HB, Allende R, Laflamme L, Laflamme J, Paradis JM, Dumont E, Doyle D, Mohammadi S, DeLarochellière R, Côté M, Laroche V, Rodés-Cabau J.

Am J Cardiol. 2015 Feb 15;115(4):472-9. doi: 10.1016/j.amjcard.2014.11.033. Epub 2014 Nov 29.

PMID:
25549880
25.

Impact of the use of transradial versus transfemoral approach as secondary access in transcatheter aortic valve implantation procedures.

Allende R, Urena M, Cordoba JG, Ribeiro HB, Amat-Santos I, DeLarochellière R, Paradis JM, Doyle D, Mohammadi S, Côté M, Abdul-Jawad O, Del Trigo M, Ortas MR, Laflamme L, Laflamme J, DeLarochellière H, Dumont E, Rodés-Cabau J.

Am J Cardiol. 2014 Dec 1;114(11):1729-34. doi: 10.1016/j.amjcard.2014.09.009. Epub 2014 Sep 16.

PMID:
25439451
26.

Transapical mitral implantation of a balloon-expandable valve in native mitral valve stenosis in a patient with previous transcatheter aortic valve replacement.

Ribeiro HB, Doyle D, Urena M, Allende R, Amat-Santos I, Pasian S, Bilodeau S, Mohammadi S, Paradis JM, DeLarochellière R, Rodés-Cabau J, Dumont E.

JACC Cardiovasc Interv. 2014 Oct;7(10):e137-9. doi: 10.1016/j.jcin.2014.02.024. Epub 2014 Sep 17. No abstract available.

27.

Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve.

Amat-Santos IJ, Dahou A, Webb J, Dvir D, Dumesnil JG, Allende R, Ribeiro HB, Urena M, Paradis JM, DeLarochellière R, Dumont E, Bergeron S, Thompson CR, Pasian S, Bilodeau S, Leipsic J, Larose E, Pibarot P, Rodés-Cabau J.

Am J Cardiol. 2014 Oct 1;114(7):1075-82. doi: 10.1016/j.amjcard.2014.07.019. Epub 2014 Jul 17.

PMID:
25132330
28.

Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation.

Ribeiro HB, Le Ven F, Larose E, Dahou A, Nombela-Franco L, Urena M, Allende R, Amat-Santos I, Ricapito Mde L, Thébault C, Clavel MA, Delarochelliére R, Doyle D, Dumont E, Dumesnil JG, Pibarot P, Rodés-Cabau J.

Heart. 2014 Dec;100(24):1924-32. doi: 10.1136/heartjnl-2014-305615. Epub 2014 Aug 14.

PMID:
25124218
29.

Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients.

Allende R, Webb JG, Munoz-Garcia AJ, de Jaegere P, Tamburino C, Dager AE, Cheema A, Serra V, Amat-Santos I, Velianou JL, Barbanti M, Dvir D, Alonso-Briales JH, Nuis RJ, Faqiri E, Imme S, Benitez LM, Cucalon AM, Al Lawati H, Garcia del Blanco B, Lopez J, Natarajan MK, DeLarochellière R, Urena M, Ribeiro HB, Dumont E, Nombela-Franco L, Rodés-Cabau J.

Eur Heart J. 2014 Oct 7;35(38):2685-96. doi: 10.1093/eurheartj/ehu175. Epub 2014 May 5.

PMID:
24796337
30.

Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era.

Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochellière R, Dumont E, Doyle D, DeLarochellière H, Laflamme J, Laflamme L, García E, Macaya C, Jiménez-Quevedo P, Côté M, Bergeron S, Beaudoin J, Pibarot P, Rodés-Cabau J.

J Am Coll Cardiol. 2014 Jun 24;63(24):2643-58. doi: 10.1016/j.jacc.2014.02.573. Epub 2014 Mar 26. Review.

31.

Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.

Ribeiro HB, Urena M, Le Ven F, Nombela-Franco L, Allende R, Clavel MA, Dahou A, Côté M, Laflamme J, Laflamme L, DeLarochellière H, DeLarochellière R, Doyle D, Dumont E, Bergeron S, Pibarot P, Rodés-Cabau J.

Am J Cardiol. 2014 Mar 1;113(5):851-9. doi: 10.1016/j.amjcard.2013.11.038. Epub 2013 Dec 12.

PMID:
24528616
32.

Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve.

Urena M, Webb JG, Cheema A, Serra V, Toggweiler S, Barbanti M, Cheung A, Ye J, Dumont E, DeLarochellière R, Doyle D, Al Lawati HA, Peterson M, Chisholm R, Igual A, Ribeiro HB, Nombela-Franco L, Philippon F, Garcia Del Blanco B, Rodés-Cabau J.

JACC Cardiovasc Interv. 2014 Feb;7(2):128-136. doi: 10.1016/j.jcin.2013.08.015. Epub 2014 Jan 15.

33.

Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function.

Urena M, Webb JG, Tamburino C, Muñoz-García AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Briales JH, Benitez LM, Al Lawati H, Cucalon AM, García Del Blanco B, López J, Dumont E, Delarochellière R, Ribeiro HB, Nombela-Franco L, Philippon F, Rodés-Cabau J.

Circulation. 2014 Mar 18;129(11):1233-43. doi: 10.1161/CIRCULATIONAHA.113.005479. Epub 2013 Dec 26.

34.

Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial.

Rodés-Cabau J, Bertrand OF, Larose E, Déry JP, Rinfret S, Urena M, Jerez M, Nombela-Franco L, Ribeiro HB, Allende R, Proulx G, Nguyen CM, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noël B, Côté M, Després JP, Dagenais GR, DeLarochellière R.

Can J Cardiol. 2014 Jan;30(1):138-45. doi: 10.1016/j.cjca.2013.11.002. Epub 2013 Nov 6.

PMID:
24365196
35.

Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.

Mok M, Nombela-Franco L, Dumont E, Urena M, DeLarochellière R, Doyle D, Villeneuve J, Côté M, Ribeiro HB, Allende R, Laflamme J, DeLarochellière H, Laflamme L, Amat-Santos I, Pibarot P, Maltais F, Rodés-Cabau J.

JACC Cardiovasc Interv. 2013 Oct;6(10):1072-84. doi: 10.1016/j.jcin.2013.06.008.

36.

Role of balloon postdilation following trancatheter aortic valve implantation.

Nombela-Franco L, Barbosa Ribeiro H, Allende R, Urena M, Doyle D, Dumont E, Delarochellière R, Rodés-Cabau J.

Minerva Cardioangiol. 2013 Oct;61(5):499-512. Review.

PMID:
24096245
37.

Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve.

Nombela-Franco L, Ribeiro HB, Urena M, Pasian S, Allende R, Doyle D, Delarochellière R, Delarochellière H, Laflamme L, Laflamme J, Jerez-Valero M, Côté M, Pibarot P, Larose E, Dumont E, Rodés-Cabau J.

EuroIntervention. 2014;9(12):1398-406. doi: 10.4244/EIJV9I12A237.

38.

Coronary obstruction following transcatheter aortic valve implantation: a systematic review.

Ribeiro HB, Nombela-Franco L, Urena M, Mok M, Pasian S, Doyle D, DeLarochellière R, Côté M, Laflamme L, DeLarochellière H, Allende R, Dumont E, Rodés-Cabau J.

JACC Cardiovasc Interv. 2013 May;6(5):452-61. doi: 10.1016/j.jcin.2012.11.014. Epub 2013 Apr 17. Review.

39.

Prognostic value of exercise capacity as evaluated by the 6-minute walk test in patients undergoing transcatheter aortic valve implantation.

Mok M, Nombela-Franco L, Urena M, Delarochellière R, Doyle D, Ribeiro HB, Côté M, Pibarot P, Delarochellière H, Laflamme L, Poirier P, Dumont E, Rodés-Cabau J.

J Am Coll Cardiol. 2013 Feb 26;61(8):897-8. doi: 10.1016/j.jacc.2012.10.050. No abstract available.

40.

Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis.

Nombela-Franco L, Ruel M, Radhakrishnan S, Webb JG, Hansen M, Labinaz M, Thompson C, Fremes S, Dumont E, DeLarochellière R, Doyle D, Urena M, Mok M, Ribeiro HB, Roifman I, Watkins S, Dumesnil JG, Pibarot P, Rodés-Cabau J.

Am J Cardiol. 2013 Apr 1;111(7):1026-33. doi: 10.1016/j.amjcard.2012.11.063. Epub 2013 Jan 22.

PMID:
23351465
41.

Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation.

Mok M, Urena M, Nombela-Franco L, Ribeiro HB, Allende R, Delarochellière R, Doyle D, Dumont E, Côté M, Rodés-Cabau J.

J Thromb Thrombolysis. 2013 May;35(4):450-5. doi: 10.1007/s11239-012-0859-7. Review.

PMID:
23269561
42.

Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation.

Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, Dager AE, Amat-Santos IJ, Cheung A, Ye J, Binder RK, van der Boon RM, Van Mieghem N, Benitez LM, Pérez S, Lopez J, San Roman JA, Doyle D, Delarochellière R, Urena M, Leipsic J, Dumont E, Rodés-Cabau J.

Circulation. 2012 Dec 18;126(25):3041-53. doi: 10.1161/CIRCULATIONAHA.112.110981. Epub 2012 Nov 13.

PMID:
23149669
43.

Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience.

Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, Feindel CM, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson M, Thompson CR, Wood D, Toggweiler S, Gurvitch R, Lichtenstein SV, Doyle D, DeLarochellière R, Teoh K, Chu V, Bainey K, Lachapelle K, Cheema A, Latter D, Dumesnil JG, Pibarot P, Horlick E.

J Am Coll Cardiol. 2012 Nov 6;60(19):1864-75. doi: 10.1016/j.jacc.2012.08.960. Epub 2012 Oct 10.

44.

Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve.

Urena M, Mok M, Serra V, Dumont E, Nombela-Franco L, DeLarochellière R, Doyle D, Igual A, Larose E, Amat-Santos I, Côté M, Cuéllar H, Pibarot P, de Jaegere P, Philippon F, Garcia del Blanco B, Rodés-Cabau J.

J Am Coll Cardiol. 2012 Oct 30;60(18):1743-52. doi: 10.1016/j.jacc.2012.07.035. Epub 2012 Oct 3.

45.

Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation.

Amat-Santos IJ, Dumont E, Villeneuve J, Doyle D, Rheault M, Lavigne D, Lemieux J, St-Pierre A, Mok M, Urena M, Nombela-Franco L, Blackburn S, Simon M, Bourgault C, Carrasco JL, Pibarot P, Côté M, Delarochellière R, Cohen DJ, Rodés-Cabau J.

Heart. 2012 Nov;98(21):1583-90. doi: 10.1136/heartjnl-2012-302185. Epub 2012 Jul 11. Erratum in: Heart. 2013 Feb;99(4):287.

PMID:
22791654
46.

First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.

Freeman M, Rodés-Cabau J, Urena M, DeLarochelliere R, Dumont E, Masson JB, Willson AB, Binder RK, Toggweiler S, Leipsic J, Wood DA, Webb JG.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):664-70. doi: 10.1002/ccd.24543. Epub 2013 Jun 25.

PMID:
22744829
47.

Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience.

Willson AB, Rodès-Cabau J, Wood DA, Leipsic J, Cheung A, Toggweiler S, Binder RK, Freeman M, DeLarochellière R, Moss R, Nombela-Franco L, Dumont E, Szummer K, Fontana GP, Makkar R, Webb JG.

J Am Coll Cardiol. 2012 Aug 14;60(7):581-6. doi: 10.1016/j.jacc.2012.02.045. Epub 2012 May 30.

48.

Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings.

Bagur R, Rodés-Cabau J, Gurvitch R, Dumont É, Velianou JL, Manazzoni J, Toggweiler S, Cheung A, Ye J, Natarajan MK, Bainey KR, DeLarochellière R, Doyle D, Pibarot P, Voisine P, Côté M, Philippon F, Webb JG.

JACC Cardiovasc Interv. 2012 May;5(5):540-551. doi: 10.1016/j.jcin.2012.03.004.

49.

Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve.

Nombela-Franco L, Rodés-Cabau J, DeLarochellière R, Larose E, Doyle D, Villeneuve J, Bergeron S, Bernier M, Amat-Santos IJ, Mok M, Urena M, Rheault M, Dumesnil J, Côté M, Pibarot P, Dumont E.

JACC Cardiovasc Interv. 2012 May;5(5):499-512. doi: 10.1016/j.jcin.2012.02.010.

50.

Transaortic transcatheter aortic valve implantation: potential issues associated with the use of the ASCENDRA transapical delivery system.

Nombela-Franco L, Rodés-Cabau J, Doyle D, Delarochellière R, Urena M, Mok M, Dumont E.

J Card Surg. 2012 Jul;27(4):438-40. doi: 10.1111/j.1540-8191.2012.01464.x. Epub 2012 May 22.

PMID:
22616946

Supplemental Content

Loading ...
Support Center